Role of percutaneous fine-needle aspiration biopsy in suspected intrathoracic malignancy

Steven D Colquhoun, Dorothy L. Rosenthal, Donald L. Morton

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Percutaneous fine-needle aspiration (PFNA) biopsy is an accepted technique for the diagnosis of suspected intra-thoracic malignancy, but the appropriate indications for its use have not been clearly defined. To help establish guidelines, we performed a retrospective analysis of 188 patients who underwent PFNA biopsy for suspected intrathoracic malignancy. Biopsy led to a diagnosis in 72% ( 135 188) of the patients, but in 27% ( 50 188) samples were inadequate for cytological diagnosis, and in 2% ( 3 188) samples were adequate but failed to yield a diagnosis. Fifty-three patients underwent surgical intervention, thus allowing histological confirmation of the cytological diagnosis. In patients with a diagnosis from PFNA biopsy, operation confirmed malignancy in 97% ( 37 38) and a specific cell type in 79% ( 30 38). In patients without a diagnosis after biopsy, a malignancy was found in 73% ( 11 15) at the time of operation. This suggests a high rate of accuracy when PFNA biopsy provides a diagnosis. However, it also illustrates that a substantial percentage of PFNA biopsy attempts fail to yield a diagnosis in patients ultimately found to have malignancies. This implies that PFNA biopsy might best be reserved for patients who are not surgical candidates.

Original languageEnglish (US)
Pages (from-to)390-393
Number of pages4
JournalThe Annals of Thoracic Surgery
Volume51
Issue number3
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Fine Needle Biopsy
Neoplasms
Biopsy
Thorax
Guidelines

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Role of percutaneous fine-needle aspiration biopsy in suspected intrathoracic malignancy. / Colquhoun, Steven D; Rosenthal, Dorothy L.; Morton, Donald L.

In: The Annals of Thoracic Surgery, Vol. 51, No. 3, 01.01.1991, p. 390-393.

Research output: Contribution to journalArticle

@article{8bce3c4bd7c54bf5914bb03912d8ca40,
title = "Role of percutaneous fine-needle aspiration biopsy in suspected intrathoracic malignancy",
abstract = "Percutaneous fine-needle aspiration (PFNA) biopsy is an accepted technique for the diagnosis of suspected intra-thoracic malignancy, but the appropriate indications for its use have not been clearly defined. To help establish guidelines, we performed a retrospective analysis of 188 patients who underwent PFNA biopsy for suspected intrathoracic malignancy. Biopsy led to a diagnosis in 72{\%} ( 135 188) of the patients, but in 27{\%} ( 50 188) samples were inadequate for cytological diagnosis, and in 2{\%} ( 3 188) samples were adequate but failed to yield a diagnosis. Fifty-three patients underwent surgical intervention, thus allowing histological confirmation of the cytological diagnosis. In patients with a diagnosis from PFNA biopsy, operation confirmed malignancy in 97{\%} ( 37 38) and a specific cell type in 79{\%} ( 30 38). In patients without a diagnosis after biopsy, a malignancy was found in 73{\%} ( 11 15) at the time of operation. This suggests a high rate of accuracy when PFNA biopsy provides a diagnosis. However, it also illustrates that a substantial percentage of PFNA biopsy attempts fail to yield a diagnosis in patients ultimately found to have malignancies. This implies that PFNA biopsy might best be reserved for patients who are not surgical candidates.",
author = "Colquhoun, {Steven D} and Rosenthal, {Dorothy L.} and Morton, {Donald L.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0003-4975(91)90851-G",
language = "English (US)",
volume = "51",
pages = "390--393",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Role of percutaneous fine-needle aspiration biopsy in suspected intrathoracic malignancy

AU - Colquhoun, Steven D

AU - Rosenthal, Dorothy L.

AU - Morton, Donald L.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Percutaneous fine-needle aspiration (PFNA) biopsy is an accepted technique for the diagnosis of suspected intra-thoracic malignancy, but the appropriate indications for its use have not been clearly defined. To help establish guidelines, we performed a retrospective analysis of 188 patients who underwent PFNA biopsy for suspected intrathoracic malignancy. Biopsy led to a diagnosis in 72% ( 135 188) of the patients, but in 27% ( 50 188) samples were inadequate for cytological diagnosis, and in 2% ( 3 188) samples were adequate but failed to yield a diagnosis. Fifty-three patients underwent surgical intervention, thus allowing histological confirmation of the cytological diagnosis. In patients with a diagnosis from PFNA biopsy, operation confirmed malignancy in 97% ( 37 38) and a specific cell type in 79% ( 30 38). In patients without a diagnosis after biopsy, a malignancy was found in 73% ( 11 15) at the time of operation. This suggests a high rate of accuracy when PFNA biopsy provides a diagnosis. However, it also illustrates that a substantial percentage of PFNA biopsy attempts fail to yield a diagnosis in patients ultimately found to have malignancies. This implies that PFNA biopsy might best be reserved for patients who are not surgical candidates.

AB - Percutaneous fine-needle aspiration (PFNA) biopsy is an accepted technique for the diagnosis of suspected intra-thoracic malignancy, but the appropriate indications for its use have not been clearly defined. To help establish guidelines, we performed a retrospective analysis of 188 patients who underwent PFNA biopsy for suspected intrathoracic malignancy. Biopsy led to a diagnosis in 72% ( 135 188) of the patients, but in 27% ( 50 188) samples were inadequate for cytological diagnosis, and in 2% ( 3 188) samples were adequate but failed to yield a diagnosis. Fifty-three patients underwent surgical intervention, thus allowing histological confirmation of the cytological diagnosis. In patients with a diagnosis from PFNA biopsy, operation confirmed malignancy in 97% ( 37 38) and a specific cell type in 79% ( 30 38). In patients without a diagnosis after biopsy, a malignancy was found in 73% ( 11 15) at the time of operation. This suggests a high rate of accuracy when PFNA biopsy provides a diagnosis. However, it also illustrates that a substantial percentage of PFNA biopsy attempts fail to yield a diagnosis in patients ultimately found to have malignancies. This implies that PFNA biopsy might best be reserved for patients who are not surgical candidates.

UR - http://www.scopus.com/inward/record.url?scp=0025978560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025978560&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(91)90851-G

DO - 10.1016/0003-4975(91)90851-G

M3 - Article

C2 - 1847797

AN - SCOPUS:0025978560

VL - 51

SP - 390

EP - 393

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -